Updates are available Erratum dated 2017-02-21
Click to view Erratum: https://doi.org/10.1038/tp.2017.13
-
Authors
Berk, M
Dandash, O
Daglas, R
Cotton, S M
Allott, K
Fornito, A
Suo, C
Klauser, P
Liberg, B
Henry, L
Macneil, C
Hasty, M
McGorry, P
Pantelis, Cs
Yücel, M
- License Information
-
More Information
Article History
Received: 4 July 2016
Revised: 13 November 2016
Accepted: 27 November 2016
First Online: 24 January 2017
Competing interests
: MB has received Grant/Research Support from Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Meat and Livestock Board, Organon, Novartis, Mayne Pharma, Servier and Woolworths, has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth and served as a consultant to Astra Zeneca, Bioadvantex, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck Merck and Servier. PM has received investigator-initiated research grants from Astra Zeneca, Janssen Cilag, Eli Lilly and BMS. He has received honoraria for educational events from Janssen Cilag, Eli Lilly, BMS, Astra Zeneca, Pfizer and Lundbeck. CP has participated on Advisory Boards for Janssen Cilag, Astra Zeneca, Lundbeck and Servier, and has received honoraria for talks presented at educational meetings organised by Astra Zeneca, Janssen Cilag, Eli Lilly, Pfizer, Lundbeck and Shire. CM has received honoraria for talks at meetings organised by Astra Zeneca, Janssen Cilag, Sanofi Synthelabo and Eli Lilly, and has been on a consultation panel for Eli Lilly. BL received funding from Svenska Läkaresällskapet (The Swedish Society of Medicine, SLS-403101), and Forskningsrådet, Karolinska Institutet, Stockholm County Council, Sweden. The remaining authors declare no conflicts of interest.
